Q&A: GenoSpace's John Quackenbush on Making Data Accessible for Research, Clinical, and Patient Use | GenomeWeb

JohnQ_pic.jpgJohn Quackenbush, the founder and CEO of GenoSpace, a Cambridge, Mass.-based bioinformatics company, was one of 13 individuals recognized by the White House's Office of Science and Technology Policy as an Open Science Champion of Change — a program that honors efforts to promote and use open scientific data and publications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.